Sarah Bennett
Vaccines are a crucial tool in the fight against infectious diseases, and their development and distribution have saved countless lives. In recent years, the focus has been on COVID-19 vaccines, with the US Food and Drug Administration (FDA) approving new shots with certain limitations. The FDA's role in authorizing and regulating vaccines is critical, but the process of approval and eligibility has sparked debates and concerns. This is especially true regarding COVID-19 vaccines for children, as the FDA's more limited approvals have raised questions about access and confusion among parents. The discussion around vaccine mandates and requirements further adds to the complexity of the topic. Understanding the FDA's role and the factors influencing vaccine approval is essential to address public health challenges and ensure the availability and effectiveness of vaccines.
| Characteristics | Values |
|---|---|
| Date of approval | 27 August 2025 |
| Vaccines approved | Moderna, Pfizer, Novavax |
| Age groups approved | Moderna: 6 months and older; Pfizer: 5 years and older; Novavax: 12 years and older |
| Additional criteria | For patients at high risk of severe illness from Covid-19 |
| Availability | Pharmacies, hospitals, and clinics |
| Insurance coverage | Unclear for healthy Americans |
| Pregnancy | No CDC guidance |
Explore related products
What You'll Learn
Covid-19 vaccines approved for high-risk groups
The US Food and Drug Administration (FDA) has approved Covid-19 vaccines, but only for those at high risk of severe illness from the virus. This includes people 65 and older, and younger people with underlying medical conditions. For children, the FDA has approved the Moderna vaccine for those older than six months, the Pfizer vaccine for those older than five years, and the Novavax shot for those older than 12. Novavax's shot is only approved for people 12 and older, not younger children. Pfizer's vaccine will no longer be available for any child under 5, as the FDA revoked the shot's emergency authorisation for that age group.
The FDA's limited approval has been criticised by some, who argue that children can still get seriously sick from Covid. Dr William Schaffner, a Vanderbilt University vaccines expert, said the limits "can't help but create barriers to vaccinations" and cause confusion.
The FDA's approval means that people who want a Covid-19 vaccine can get one after consulting with a doctor. However, the narrower approval may limit access to shots for some people who were previously able to get them. It is also unclear how easily patients without high-risk factors will be able to get a Covid vaccine, and whether insurance plans will still cover the shots for healthy people.
The CDC's website lists several underlying medical conditions that put people at higher risk of severe Covid-19, including cancer, obesity, diabetes, chronic kidney disease, and heart disease.
It is important to note that the availability and eligibility criteria for Covid-19 vaccines may vary depending on local regulations and recommendations.
Religious Exemptions: Why Some Refuse Vaccines
You may want to see also
Explore related products
Vaccines for children
Vaccines are an important way to protect children from serious and deadly diseases. In the US, every state and Washington, D.C., requires vaccines for children to attend school. However, there has been a recent decline in childhood vaccinations. In Florida, for example, vaccine mandates for students are being eliminated.
The Vaccines for Children (VFC) Program was created in 1993 in response to a measles epidemic that resulted in tens of thousands of cases and hundreds of deaths. Over half of the children who contracted measles had not been vaccinated, with the cost of the vaccine being a primary reason. The VFC Program provides vaccines at no cost to eligible children through enrolled public and private healthcare providers. It is an entitlement program for children aged 18 and younger and has helped to ensure that all children have a better chance of getting their recommended vaccinations on schedule. The program covers vaccines recommended by the Advisory Committee on Immunization Practices (ACIP) and approved by the CDC, including vaccines that protect against 19 different diseases.
The approval of COVID-19 vaccines for children has been a controversial topic. Initially, Pfizer's COVID-19 vaccine was approved for children ages 6 months to 4 years. However, with the latest round of approvals, the FDA has ended its broader authorization, only clearing the vaccines for people at higher risk of severe illness. Pfizer's updated COVID-19 vaccine is now approved for ages 5 and up, Moderna's for 6 months and up, and Novavax's for ages 12 and up, but only for those at higher risk. This has caused confusion and concern for parents, especially as there is no longer a recommendation for pregnant women, who are also at higher risk.
Despite the controversy and changing recommendations, it is important for parents to have access to vaccines for their children and to stay up to date with recommended vaccine schedules.
Restaurant Workers: AZ Vaccine Eligibility
You may want to see also
Explore related products
Vaccination during pregnancy
Vaccination is crucial during pregnancy to protect both the mother and the baby from potentially serious diseases. The flu, Tdap (tetanus, diphtheria, and pertussis), respiratory syncytial virus (RSV), and COVID-19 vaccines are recommended for pregnant women. These vaccines help create protective antibodies that can be passed on to the baby, offering early protection against these diseases.
Pregnancy causes changes in immune, heart, and lung functions, making women more susceptible to severe illnesses from the flu and COVID-19. The flu vaccine can be administered during any trimester and is crucial for protection during the flu season. The Tdap vaccine is recommended between the 27th and 36th weeks of pregnancy, preferably earlier in this period. The RSV vaccine can be administered during weeks 32 to 36 of pregnancy, from September to January, to protect the baby from severe respiratory illness.
The MMR (measles, mumps, rubella) vaccine is essential before pregnancy. Women should ensure they are up to date with this vaccine and wait at least one month after receiving it before becoming pregnant. The COVID-19 vaccine is also recommended during pregnancy to protect both mother and baby from severe illness. Pregnant women are encouraged to consult their doctors and stay up to date with their COVID-19 vaccinations.
While vaccination during pregnancy is generally safe, mild side effects such as fever, tiredness, body aches, redness, swelling, and tenderness at the injection site may occur. However, the CDC and a panel of experts have reviewed safety data and concluded that these vaccines are not harmful to pregnant women or their babies.
In terms of vaccine approval, the FDA has authorized specific COVID-19 vaccines for different age groups and high-risk individuals. The approval process for vaccines involves the FDA evaluating clinical data on safety and effectiveness. The CDC also plays a role in providing clinical guidance and recommendations for vaccine use.
Vaccines at 13: What You Need to Know
You may want to see also
Explore related products
FDA approval process
The U.S. Food and Drug Administration (FDA) is responsible for ensuring the safety and efficacy of drugs, medical devices, and vaccines before they are marketed. The FDA approval process for drugs and vaccines involves a structured framework to determine if the benefits of a drug or vaccine outweigh its known and potential risks for the intended population. This process can be lengthy, typically taking 12 to 15 years for drugs and 3 to 7 years for medical devices.
The FDA's Center for Drug Evaluation and Research (CDER) oversees the drug approval process, evaluating safety, efficacy, and labeling. The process includes analyzing the target condition and available treatments to provide context for weighing risks and benefits. Strategies for managing risks include FDA-approved drug labels that clearly describe benefits and risks, and in some cases, a Risk Management and Mitigation Strategy (REMS) may be required.
The FDA employs several approaches to encourage the development of certain drugs, such as Fast Track, Breakthrough Therapy, Accelerated Approval, and Priority Review. These designations aim to expedite the approval process for drugs that represent the first available treatment for an illness or offer significant benefits over existing options. Accelerated Approval, for instance, uses a "surrogate endpoint" to predict clinical benefit, allowing promising therapies for serious conditions to reach the market quicker.
For medical devices, the FDA's Center for Devices and Radiological Health (CDRH) oversees the approval process. There are three basic processes for obtaining marketing approval: the PMA (pre-market approval) process, the PMN (pre-market notification) process, and the humanitarian device exemption (HDE) process. Class III devices, which pose greater risks to patients, typically require pre-market approval and clinical evidence to support the application.
The FDA approval process for vaccines follows similar rigorous procedures to ensure their safety and efficacy. For example, during the COVID-19 pandemic, the FDA approved updated vaccines with certain limitations on their use, demonstrating their role in evaluating and authorizing vaccines for specific populations.
Traveling to Ireland: Quarantine Rules for Vaccinated People
You may want to see also
Explore related products
FDA's limited approval
In May 2025, the US Food and Drug Administration (FDA) announced changes to its COVID-19 vaccine policy, limiting approved indications to adults over 65 and individuals at higher risk of severe illness. This means that only those at higher risk of severe illness from the virus, including adults 65 and older and younger people with specific medical conditions, are approved to receive the updated COVID-19 vaccines.
The FDA's more limited approval has been met with some criticism. Dr. Susan Kressly, president of the American Academy of Pediatrics, expressed concern, particularly regarding respiratory illnesses like COVID-19, which can be risky for infants and toddlers. She advocated for parental access to the vaccine for their children. Kennedy, on the other hand, highlighted the availability of the shots for all patients who choose them after consulting their doctors, although the ease of access for patients without high-risk factors remains unclear.
The FDA's limited approval has also resulted in confusion and stress for parents, as there is no clear CDC guidance for certain groups, such as pregnant women. Additionally, the approval may restrict access to the vaccine for some individuals who were previously able to receive it. Despite these concerns, the FDA maintains that 100% of adults can still obtain the vaccine if they choose to, and healthcare providers can provide the vaccine "off-label" for those who do not meet the new eligibility criteria.
The FDA's decision to limit approval for the COVID-19 vaccine is not an isolated incident. Historically, the FDA has been criticised for the length of its drug approval process, particularly during the AIDS epidemic, which led to expedited approval mechanisms for drugs treating life-threatening diseases and expanded pre-approval access for patients with limited treatment options.
Vaccines for Your Pet: Filing an Insurance Claim
You may want to see also
Frequently asked questions
Yes, a vaccine has to be approved by the FDA to be administered to the public.
FDA approval means that the Food and Drug Administration has reviewed and authorised the use of a vaccine.
The FDA Commissioner, along with the US Health and Human Services Secretary, reviews and approves vaccines.
Yes, as of August 2025, the FDA approved updated COVID-19 vaccines from Pfizer, Moderna, and Novavax with certain restrictions.
The FDA has restricted the use of the updated COVID-19 vaccines to people at high risk of COVID-19 complications, including seniors, younger adults, and children with at least one high-risk health condition.
